Type 1 Diabetes with Low Blood Sugar 
Trial Opportunity

Why Join

Are there other options for managing low blood sugar from Type 1 Diabetes?

If you have asked yourself this question, consider enrolling in the CATT1 study, which is researching a study drug that may help.
We are testing a new treatment to help manage blood sugar levels in people with Type 1 Diabetes. This treatment aims to keep your blood sugar more stable without increasing the risk of low blood sugar (hypoglycemia) or high blood acid levels (ketoacidosis).

This study is funded by BreakthroughT1D (former JDRF).

Study participants receive:

  • Possible access to a study drug
  • Some participants will receive a placebo, which has no active ingredients
  • Study support and monitoring by a healthcare team
  • Education about diabetes and hypoglycemia
  • Compensation for your time and participation
  • The opportunity to help advance type 1 diabetes mellitus research

Trial Process

Screening Period
≤ 2 weeks
Number of visits: V1
Device Training and Insulin Adjustment Period
≤ 4 weeks
Number of visits: V2
Baseline Assessment Period
4 weeks
Number of visits: V3
Double-Blind Treatment Period
52 weeks
Number of visits: V5 - V13
Follow-up Period
4 weeks
Number of visits: V14

Participants will be divided into three groups. One group will take the new treatment once a day with a placebo. Another group will take the new treatment twice a day. The third group will take a placebo twice a day. A placebo is a pill that does not contain any medicine. This helps us compare the effects of the new treatment.

Trial Goals

Are you struggling to manage low blood sugar from 
type 1 diabetes? 
If so, you may be interested in joining the CATT1 study.

The aim of this trial

We are studying a new treatment for people with Type 1 Diabetes. Our goal is to help people manage their blood sugar levels better without increasing the risk of low blood sugar or a serious condition called ketoacidosis.

Requirements
for participants

Participants must have Type 1 Diabetes.

Participants must be within a certain age range.

All genders are welcome.

Participants must have experienced low blood sugar episodes (<54 mg/dl) within the last 2 months.

Trial Locations

Total sites1Map is Loading...

Check your
eligibility
in two minutes